Brazil Digestive Remedies Market to Reach USD 1.11 Billion by 2032, Says Vyansa Intelligence [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Intelligence, the Brazil Digestive Remedies Market is projected to grow at a CAGR of around 1.8% during 2026–2032. The market growth is primarily driven by the rising prevalence of digestive disorders, increasing consumption of processed and fast foods, and strong demand for over-the-counter (OTC) remedies across Brazil. Vyansa Intelligence Logo Brazil Digestive Remedies Market Key Takeaways The Brazil Digestive Remedies Market was valued at approximately USD 980 million in 2025 and is estimated to reach USD 985.8 million in 2026, further projected to grow to around USD 1.11 billion by 2032, reflecting a steady expansion driven by consistent consumer demand for digestive health products. By product type, indigestion & heartburn remedies dominate the market, accounting for nearly 54% share, supported by the widespread incidence of acid reflux, gastric discomfort, and lifestyle-related digestive issues. By sales channel, retail offline dominates with nearly 85% share, driven b
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson (JNJ) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $255.00 price target on the stock.MarketBeat
- The Low-Volatility Promise of ACWV Costs Investors 118% Over a Decade Compared to SPY [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases [Yahoo! Finance]Yahoo! Finance
- AtaiBeckley Weighs BPL-003 Deal After Strong Phase 2a And FDA Support [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson Oncology And Immunology Advances Test Valuation Story [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website